Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Brain : a Journal of Neurology|April 17, 2024
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesisJesse Huang, Katarina Tengvall, Izaura Bomfim Lima, et al.Journal of the National Cancer Institute|May 24, 2018
Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent PopulationsBritton Trabert, Tim Waterboer, Annika Idahl, et al.European Urology Oncology|November 10, 2023
Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 YearsChristian A Moen, Thea E Falkenthal, Tor K Thorkelsen, et al.American Journal of Human Genetics|January 17, 2024
A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection and allergyAmanda Y Chong, Nicole Brenner, Andres Jimenez-Kaufmann, et al.European Journal of Neurology|June 9, 2021
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.Cancer|January 11, 2021
Timing, number, and type of sexual partners associated with risk of oropharyngeal cancerVirginia E Drake, Carole Fakhry, Melina J Windon, et al.Journal of Clinical Microbiology|August 23, 2019
Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for StandardizationZhiwei Liu, Kelly J Yu, Anna E Coghill, et al.Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis riskKatarina Tengvall, Jesse Huang, Cecilia Hellström, et al.Frontiers in Immunology|February 11, 2020
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple SclerosisElin Engdahl, Rasmus Gustafsson, Jesse Huang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Baseline Biomarkers for Outcome of Melanoma Patients Treated with PembrolizumabBenjamin Weide, Alexander Martens, Jessica C Hassel, et al.Pageof 6